Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2026-01-01 @ 6:16 PM
Study NCT ID:
NCT04128956
Status:
TERMINATED
Last Update Posted:
2024-03-01
First Post:
2019-10-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS
Sponsor:
University of Zurich
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-03-11
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-21
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-14
First Submit QC Date:
None
Study First Post Date:
2019-10-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-27
Last Update Post Date:
2024-03-01
Last Update Post Date Type:
ACTUAL